1 asset in Mitochondrial Trifunctional Protein Deficiency

Therapeutic assets addressing Mitochondrial Trifunctional Protein Deficiency, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cald Hr-D Mitochondrial Trifunctional Protein Deficiency	Masonic Cancer Center, University of Minnesota	P2	CCC (53)